Sinapic acid attenuated nephrotoxicity against Cyclophosphamide in mice model: A histochemical, immunohistochemical and histopathological evaluation

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 241

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-28-5_013

تاریخ نمایه سازی: 15 اسفند 1403

چکیده مقاله:

Objective(s): Cyclophosphamide (CP) is a chemotherapeutic drug used to treat various tumors. It causes nephrotoxicity by producing reactive oxygen species. Sinapic acid (SA) exhibits anti-oxidant, antiapoptotic, and anti-inflammatory activities at low doses as a phenylpropanoid. This study aimed to investigate the protective effects of SA on SP-induced renal injury. Materials and Methods: Forty-eight BALB/c mice were randomly divided into control, SA (for seven consecutive days, with two doses of ۵ and ۱۰ mg/kg), CP (single dose, ۲۰۰ mg/kg), and CP + SA (۵ and ۱۰ mg/kg). On the ۱۰th day of the study, mice were examined by renal function markers (Urea and Creatinine), oxidative stress markers (MDA and GSH), histopathological, and immunohistochemical assays (caspase-۳ and NF-kB kidney). Results: MDA levels increased and GSH levels decreased significantly in CP-treated mice. In addition, the histopathological structure of the kidney tissue in CP-treated mice showed significantly severe kidney tissue damage associated with increased urea and creatinine. The administration of SA in CP-treated mice significantly reduced serum urea and creatinine concentrations. In addition, the immunohistochemical staining of caspase- ۳ and NF-kB decreased significantly in the CP + SA group compared to CP-treated mice. Conclusion: Overall, our study suggests that sinapic acid, a substance with antioxidant, antiapoptotic, and anti-inflammatory properties, can be used as a complementary therapy to protect nephrotoxicity against CP.

نویسندگان

Saeed Raoof

Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Shiva Rezaei

Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Mehryar Zargari

Department of Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Masooreh Mirzaei

Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Seyed Jalal Hosseinimehr

Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Abbasali Karimpour Malekshah

Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Fereshteh Talebpour Amiri

Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Puyo S, Montaudon D, Pourquier P. From old alkylating agents ...
  • Highley MS, Landuyt B, Prenen H, Harper PG, De Bruijn ...
  • Mills KA, Chess-Williams R, McDermott C. Novel insights into the ...
  • Gulcin İ. Anti-oxidants and anti-oxidant methods: An updated overview. Arch ...
  • Taslimi P, Kandemir FM, Demir Y, İleritürk M, Temel Y, ...
  • Galal SM, Mansour HH, Elkhoely AA. Diallyl sulfide alleviates cyclophosphamide-induced ...
  • Dhanisha SS, Drishya S, Guruvayoorappan C. Pithecellobium dulce fruit extract ...
  • Alshahrani S, Ali Thubab HM, Ali Zaeri AM, Anwer T, ...
  • Nićiforović N, Abramovič H. Sinapic acid and its derivatives: Natural ...
  • Pandi A, Kalappan VM. Pharmacological and therapeutic applications of sinapic ...
  • Hu X, Geetha RV, Surapaneni KM, Veeraraghavan VP, Chinnathambi A, ...
  • Ahmad A, Alkharfy KM, Bin Jardan YA, Shahid M, Ansari ...
  • Ansari MA. Sinapic acid modulates Nrf۲/HO-۱ signaling pathway in cisplatin-induced ...
  • Rezaei S, Hosseinimehr SJ, Zargari M, Karimpour Malekshah A, Mirzaei ...
  • Taghizadeh F, Hosseinimehr SJ, Zargari M, Karimpour Malekshah A, Talebpour ...
  • Altındağ F, Ergen H. Sinapic acid alleviates cisplatin-induced acute kidney ...
  • Ansari MA, Raish M, Ahmad A, Alkharfy KM, Ahmad SF, ...
  • Ansari MA, Raish M, Ahmad A, Ahmad SF, Mudassar S, ...
  • Şimşek H, Küçükler S, Gür C, Akaras N, Kandemir FM. ...
  • Ahmad Ansari M, Shahid M, Ahmad SF, Ahmad A, Alanazi ...
  • Said E, Elkashef WF, Abdelaziz RR. Tranilast ameliorates cyclophosphamide-induced lung ...
  • Sinanoglu O, Yener AN, Ekici S, Midi A, Aksungar FB. ...
  • Lin X, Yang F, Huang J, Jiang S, Tang Y, ...
  • Alaofi AL. Sinapic acid ameliorates the progression of streptozotocin (STZ)-induced ...
  • Singh HP, Singh TG, Singh R. Sinapic acid attenuates cisplatin-induced ...
  • El-Shabrawy M, Mishriki A, Attia H, Emad Aboulhoda B, Emam ...
  • Caglayan C, Temel Y, Kandemir FM, Yildirim S, Kucukler S. ...
  • Ansari MA, Raish M, Ahmad A, Alkharfy KM, Ahmad SF, ...
  • Ghareeb MA, Sobeh M, El-Maadawy WH, Mohammed HS, Khalil H, ...
  • HAS AL, Alotaibi MF, Bin-Jumah M, Elgebaly H, Mahmoud AM. ...
  • نمایش کامل مراجع